Ashvattha Therapeutics

0 followers

‌

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Industries

Biotechnology

Headquarters

Redwood City, United States

Employees

11-50

Links

Org chart

Jeffrey L. Cleland

Chairman, President & CEO

Jeffrey L. Cleland

Collapse

Steve Carlos

VP, Manufacturing

Debra Nguyen

Sr. Manager, Accounting

Jay Z.

Board Director

Jeannie Skinner

Head of Regulatory Affairs

Christine S.

Director, Project Management

Naze Gul Avci, Ph.D.

Senior Scientist

S. Sakura Minami

VP Translational Medicine And Nonclinical Development

Teams

Scientific Teams

6 members

Scientific Advisory Team

6 members

Leadership Team

2 members

Similar companies

Tango Therapeutics

2 followers

Septerna

2 followers

Kyverna Therapeutics

6 followers

Day One Biopharmaceuticals

1 follower

Capricor Therapeutics

1 follower

QurAlis

1 follower

Cargo

1 follower

Abcuro

1 follower

Ultima Genomics

3 followers

Thermo Fisher Scientific

173 followers

Gilead Sciences

132 followers

Explore companies

��������